Intraoperative Extracorporeal Support in Lung Transplantation: Where Are We Heading?
A review of the Journal of Clinical Medicine on intraoperative support during lung transplantation compares the use of ECMO with cardiopulmonary bypass.
A review of the Journal of Clinical Medicine on intraoperative support during lung transplantation compares the use of ECMO with cardiopulmonary bypass.
A retrospective analysis of the United Network for Organ Sharing (UNOS) database on heart transplants from controlled circulatory death (DCD) donations performed in the U.S. from October 2018 to December 2022.
This international, multicenter clinical trial (DanGer study) evaluates the effects of routine implantation of the microaxial flow pump (Impella CP®) compared to conventional treatment in patients with acute myocardial infarction complicated by cardiogenic shock.
An expert commentary by Dra. Sonia Mirabet about choices for advanced heart failure therapies.
A systematic review analyzing nearly 1000 pediatric Berlin Heart® implants to describe the characteristics of patients who achieved successful explantation.
This study, conducted at a tertiary pediatric cardiology center, evaluates the long-term use of ventricular assist devices (VADs).
This state-of-the-art document discusses current guidelines on indications and utility of invasive hemodynamic assessment in patients with advanced heart failure (HF) undergoing treatment with continuous-flow left ventricular assist devices (LVADs).
Review article from Thoracic and Cardiovascular Surgeon that revisits the most relevant articles published in 2022 in the field of cardiac surgery.
This JACC scientific statement summarizes the progress and challenges of durable ventricular assist devices (VADs) for patients with advanced heart failure, contextualizing current therapy and outcomes, and discussing future technology and priorities.
Outcomes of VA-ECMO weaning for cardiogenic shock of various etiologies at Columbia University Irving Medical Center, assessed at both 30-day/hospital discharge and 1-year follow-up among survivors.